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Karen L. Knox(l) and Alison H. Holmes(2) 
Approximately 10% of hospital in-patients in the UK acquire nosocomial infection, with an increasing number of 
these infections caused by multiresistant organisms. It is essential to halt the development and spread of antibiotic 
resistance among hospital pathogens. 
The relationship between antibiotic use and the development of antibiotic resistance in microorganisms is a subject 
of ongoing controversy and research. However, there is a general acceptance that control of antibiotic prescribing 
within hospitals is fundamental to controlling the development of nosocomial antibiotic resistance. In order to 
achieve this, there is a need to design and successfully implement targeted antibiotic policies based on local patterns 
of resistance. Traditional educational methods used alone for executing such policies have not been shown to be 
effective. Computer-based technology shows great promise but will require considerable resource allocation for its 
installation. 
Of equal importance, the Infection Control Team must be given a high profile. Robust surveillance systems to gather 
epidemiological data on local prescribing practices, hospital infection control policy compliance, antibiotic resistance 
and hospital infection rates need to be set up within individual hospitals. The appointment of an anti-infective 
pharmacist should be considered. Delivery of an integrated antibiotic and infection control service requires a co- 
ordinated, multidisciplinary team approach with clear leadership. Finally, in order for any strategy to be successful, 
the full support of hospital management is essential. 
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The concern about the development of antimicrobial 
resistance among organisms associated with nosocomial 
infection is not new.1-3 Antimicrobial resistance within 
some hospital organisms however, has reached the point 
where currently available antimicrobial agents are no 
longer effective. Clinical dilemmas include an increasing 
number of serious infections caused by extended- 
spectrum beta-lactamase-producing Enterobacteriaceae, 
methicillin-resistant Staphylococcus aureus, vancomycin- 
resistant Enterococci and multiresistant Acinetobacter 
spp. There is a substantial increase in morbidity and 
mortality associated with infections caused by these 
resistant organisms as well as an increase in cost of 
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patient care (prolonged hospital stay, use of more 
expensive antibiotics). 4~5 With approximately 10% of in- 
patients in the UK acquiring nosocomial infectionj, 
there is now, more than ever before, an urgent need 
for a concerted effort to control and prevent further 
development and spread of antimicrobial resistance 
within the hospital setting.7-9 
ANTIMICROBIAL AGENT USE AND 
DEVELOPMENT OF ANTIMICROBIAL 
RESISTANCE 
There have been sufficient reports of the association of 
antimicrobial usage in hospitals with the emergence of 
antibiotic resistance to implicate it as a causal factor.4 
The observations first, that antimicrobial resistance is 
more prevalent in bacterial strains causing nosocomial 
infections, and second, that those areas in the hospital 
with the highest antimicrobial usage have the highest 
prevalence of antibiotic-resistant bacteria (i.e. intensive 
care and burns units) lend further support to this associ- 
ation. In the United States, an ongoing multi-centre 
surveillance study, Project ICARE (Intensive Care 
Antimicrobial Resistance Epidemiology) is providing 
valuable data that will contribute to the understanding 
of the complex relationship between antimicrobial use 
and resistance.lO There is currently no comparable study 
being undertaken in the UK. 
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CONTROLLING ANTIMICROBIAL USE AND 
DECREASED RESISTANCE 
It may seem intuitive that by controlling anti- 
microbial prescribing, a subsequent reduction in 
antibiotic resistance will occur. However, this is not easy 
to prove. Examples from the wider community lend 
support. A considerable reduction in the prevalence 
of erythromycin-resistant Streptococcus pyogenes in 
Finland was demonstrated after a national campaign to 
reduce the use of macrolide antibiotics.li Similarly, the 
abolition of certain antibiotics from animal feed in 
Denmark has led to a decline in resistance in faecal flora 
from food animalsI 
Results of studies of antimicrobial control strategies 
in the hospital environment are equally suggestive; 
antibiotic control interventions have resulted in a 
decrease in extended-spectrum beta-lactamase-pro- 
ducing Enterobacteriaceae in both Intensive Care Unit 
(ICU) and non-ICU settings.13J4 Data are often 
inconclusive however, not least because they are 
hampered by lack of standard definitions of resistance as 
well as variation in susceptibility testing. Data are also 
often collected from outbreak situations where con- 
founding factors, such as a step up in infection control 
precautions, are difficult to control for. Changes in 
antibiotic resistance depend also upon other factors, 
including the intrinsic nature of the resistance mechan- 
ism in the organism, e.g. if an additional phenotypic 
advantage is concomitantly conferred, antibiotic resist- 
ance may persist in the absence of selective pressure.15J6 
Acknowledgement of the complicated relationship 
between antimicrobial use and changes in resistance in 
microorganisms is important particularly when com- 
municating with clinical colleagues with regard to the 
issue of antibiotic control. This is a clear area for further 
research. 
Although there is a recognized need for better data 
from controlled multi-centre studies, the consensus 
among healthcare professionals within the field of 
infection is that control of antimicrobial prescribing 
is one of the keystones to controlling antimicrobial 
resistance within hospitals. 7,8 Antimicrobial prescribing 
should be controlled, but the questions remain as to the 
optimal control measures and how best to implement 
them. 
DEFINING THE PROBLEM 
In order to have any useful impact upon antimicrobial 
prescribing and antibiotic resistance within an individual 
hospital, the epidemiology of prescribing practices and 
local antibiotic resistance patterns need to be defined. 
This is essential to enable identification of potential 
problem areas and for audit, feedback and follow-up 
purposes. Serial point prevalence studies to monitor 
prescribing practices provide a useful starting point for 
the quantification of antibiotic use within the hospital 
setting as well as for providing a reference point by 
which to gauge the impact of any control intervention 
(Dr. B. Dean, unpublished data). Many hospitals in the 
UK have traditionally been very poor at collecting and 
collating such data into a useful format.17 Lack of 
administrative and information technology (IT) support, 
funding and resources, as well as under-recognition of 
the extent of the problem of poor prescribing practices 
are contributing factors. Within National Health Service 
hospitals, there are few, if any, existing organizational 
frameworks for the generation and processing of these 
sort of epidemiological data. Public health frameworks 
need to be promoted and expanded within the hospital 
setting in the UK. 
STRATEGIES FOR CONTROL 
Measures for restraint or control of antibiotic 
prescribing have historically been resisted by many 
physicians and surgeons in the UK and worldwide,4J7 
not least because they may be seen as a curb on or 
loss of autonomy for the prescriber, who is ultimately 
responsible for individual patient care. There is a need 
to understand the many determinants that shape 
antibiotic prescribing in order to devise and implement 
effective programmes to reduce inappropriate use. In 
the hospital setting in particular, prescribing decisions 
are often made by those with least clinical experience 
(junior on-call). The pressures of bed and staffing 
shortages lead to a drive to reduce in-patient stays. 
There are increasing numbers of patients who, either 
as a result of immunosuppression or the presence of 
indwelling prosthetic devices, are more susceptible to 
infection. The low threshold for prescribing either 
prophylactic or empirical antibiotics increases the 
likelihood of inappropriate antibiotic use in this patient 
population in particular. These factors together with 
(mis-)information regarding local antimicrobial resist- 
ance patterns may all contribute to the likelihood of the 
prescribing of unnecessary and costly broad-spectrum 
antibiotics.18J9J0 
In addition, changes to the UK medical under- 
graduate curriculum have served to reduce the amount 
of time dedicated to microbiology and infection-related 
topics, which, in turn, may undermine their importance 
for the future generation of healthcare professionals. 
In the UK, the medical profession has come under 
close public and governmental scrutiny (media cover- 
age, government monitoring agencies: Commission for 
Health Improvement; National Institute for Clinical 
Excellence). Thus, accountability and the need to 
practice evidence-based medicine further provide strong 
arguments for curbing inappropriate and excessive 
antibiotic prescribing with all its attendant risks. The 
need for careful management of antimicrobial use must 
be communicated more clearly and effectively to clinical 
colleagues, along with acceptable policies and ways by 
which to implement them.7-9 
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ANTIBIOTIC POLICIES AS THE BASIS FOR 
GUIDING ANTIBIOTIC USE 
With around 20% of the hospital drug budget in UK 
hospitals being attributable to antimicrobial costs,17 
antibiotic policies and control programmes based on 
local antimicrobial resistance patterns are the key to 
effecting appropriate antibiotic use within the hospital 
setting.7-9 Some restriction to the spectrum and 
prescription of antibiotics that are included in the 
hospital formulary is fundamental to the development 
of such policies. Specific areas that may be successfully 
targeted for control include surgical prophylaxis (which 
constitutes a large proportion of hospital antibiotic use), 
as well as empirical and targeted treatment of com- 
monly encountered infections (in the form of local treat- 
ment guidelines). In order for policies to be successful, 
they need to be acceptable to clinical colleagues (i.e. 
appropriate consultation prior to inception) and easily 
accessible (portable/electronic formats), as well as 
being continuously updated (in accordance with both 
local resistance patterns and national guidelines) and 
monitored for compliance. 
Good communication needs to be established 
between laboratory staff, infectious disease profes- 
Table 1. Steps to control development and spread of 
antimicrobial resistance within hospitals 
Set up multidisciplinary hospital epidemiology team to 
integrate infection and antibiotic control. Include: consultant 
(microbiologist/infectious diseases/hospital epidemiologist); 
pharmacist (infectious diseases pharmacist); infection control 
team; BMS; data management and IT support. 
Recognize that the support of hospital administration and 
leadership is mandatory: accountability for implementation of 
policies. 
Develop coordinated comprehensive surveillance system 
for monitoring of local epidemiology of antimicrobial 
resistance and hospital-acquired infection and of antibiotic 
prescribing. 
Improve antibiotic prescribing: 
(a) Set up antibiotic steering group/antibiotic committee: 
responsible for (b). Must have hospital leadership backing. 
(b) Develop antibiotic policies based upon local surveillance 
data: easily accessible hospital formulary; surgical prophylaxis 
guidelines and local treatment guidelines for commonly 
encountered infections; restricted range of available antibiotics; 
automatic stop dates; limited susceptibility reporting; control of 
pharmaceutical sales promotion. 
(c) Implement effective antibiotic policies: educational 
campaigns; structured educational order forms; computer- 
assisted decision support systems; one-on-one educational 
outreach; requirement for prior authorization for restricted 
antibiotics. 
Raise profile of Infection Control Team and its activities. 
Regularly review and update policies, measurement of 
outcomes. 
Set up active feedback to hospital staff: creation of formal 
pathway for communication between hospital epidemiology 
team and ward-based clinicians. 
BMS, biomedical scientist 
sionals and clinicians. Important relevant information 
(changes in local sensitivity patterns, resistance rates, 
rates of unit-specific hospital-acquired infection) should 
be readily available and may facilitate implementation 
of policies if disseminated within a regular feedback 
forum. 
Other aspects of antibiotic control policies include 
automatic stop dates, regular review of prescriptions 
with tailoring of therapy based on microbiological 
results and clinical response, limited susceptibility 
reporting by the laboratory, and the control of pharma- 
ceutical sales promotions. Clearly, it is necessary to 
identify a person or persons within an individual 
hospital, to whom the responsibility of co-ordinating any 
control programme falls. 
Inappropriate and excessive antibiotic prescribing is 
still a major problem within UK hospitals.17 This is a 
poor reflection of our ability to implement antibiotic 
policies effectively. 
IMPLEMENTATION OF POLICIES 
Current systems for implementing antibiotic policies 
and thus improving precision of antibiotic prescribing 
include both paper-based and computer-based tech- 
nology (Table 1). Passive education alone (lectures, 
educational events, leaflets, handouts) has not been 
shown to be effective in improving clinical practice 
either in the short or long term.1s,20,21,22 In the UK this 
may be partly a result of the rapid turnover of junior 
staff and the difficulty in maintaining a continuous 
educationtil programme. l8 When passive education is 
combined with interactive interventions, for example 
active discussions with heads of clinical programmes22 
or structured educational order forms,23 the results are 
considerably better. 
Several computer-assisted decision support systems 
have been shown to be successful in guiding and 
monitoring antibiotic prescribing. Success has been 
achieved on all fronts: acceptability to clinicians, 
decrease in prevalence of multi-resistant organisms 
within specialized units, decrease in numbers of adverse 
drug reactions, cost reductions; all with no documented 
clinical adverse outcome on in-patient care.19,24,25 
Computer-based technology shows great promise but 
requires considerable financial and technical input, 
which, within the framework of the NHS (individual 
trust-based computer systems, interfacing problems 
between laboratory and ward-based systems), is not 
likely to be an achievable goal in the near future. 
Another system is that of individual ‘academic 
detailing’,26 which is a one-to-one educational approach 
programme based on established principles of behavioural 
science and market research and communications 
theory. This has been shown to be effective in improving 
the accuracy and appropriateness of drug prescription as 
well as being cost effective. 
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A strategy requiring prior authorization for selected 
antibiotic agents is employed within many hospitals 
within the UK and elsewhere, and has been shown to 
improve antimicrobial susceptibilities when imple- 
mented rigorously. 27 Again, to be successful, this 
approach requires close cooperation between senior and 
junior clinical staff. 
ROLE OF AN ANTI-INFECTIVE PHARMACIST 
Currently the personnel who oversee the implemen- 
tation of antibiotic policies include microbiologists and 
infectious diseases physicians, along with the infection 
control team and clinical pharmacists. The British 
Society for Antimicrobial Chemotherapy working party 
report suggests expanding the role of the clinical 
pharmacist in the UK still further.17 The appointment of 
a specialist anti-infective pharmacist within a single 
London hospital resulted in considerable savings within 
1 year.7 The initial remit of the pharmacist in this 
particular case included education and advice regarding 
anti-fungal use. Thus the potential for further gain in 
terms of improving antibiotic use in general (as well as 
cost savings) is vast. 
An overwhelming interest following a UK national 
survey has resulted in the development of a network for 
pharmacists with an interest in anti-infective agents.28 
This is aimed at promoting the vital role of infectious 
disease pharmacists, the dissemination of information 
regarding and optimization of antimicrobial prescribing 
in the UK. The anti-infective pharmacist should be seen 
as part of an integrated and multidisciplinary team that 
is responsible for facilitating good antimicrobial use 
within hospitals. 
CONTROLLING ANTIBIOTICS: ONLY PART OF 
THE PICTURE 
Many factors lead to the development and dissemin- 
ation of antibiotic resistance within nosocomial patho- 
gens. Rationalizing the use of antimicrobial agents is 
only a part of the picture and cannot be viewed in 
isolation29(Table 1). In order to reduce the burden of 
hospital-acquired infection, caused by both sensitive and 
resistant organisms, the rate of transmission of these 
organisms must be checked. Knowledge of the epidemi- 
ology of local resistance patterns and infection rates (i.e. 
active and ongoing surveillance) is fundamental to 
gauging the effectiveness of any control programmes. To 
this end, hospitals must be equipped with adequate IT 
functions and the infrastructure for record keeping 
and surveillance purposes. There is also a need for 
uniformity of antimicrobial sensitivity testing methods 
and application of standardized consensus definitions of 
infection and resistance, which will allow comparison of 
data between and within hospitals on a more meaningful 
basis. 
Stringent infection control measures must be 
enforced in order to reduce spread of infection within 
hospitals. 3o The role of the Infection Control Team 
(ICT) must be given the importance that it deserves. 
Infection control campaigns have in the past, and 
currently, met with resistance perhaps because they 
are seen as punitive and separate to, rather than as a 
necessary part of, clinical practice. Behavioural change 
is a large part of infection control practice, and is 
notoriously difficult to effect. There seems to be a 
general reluctance amongst clinical staff to take 
responsibility for maintaining good infection control 
practice. Even to try to ensure compliance with basic 
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control teams 
I 
Development of 
antibiotic policies 
Surveillance of hospital-acquired 
resistance & infection rates; 
compliance with policies 
f 
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infection control 
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/. 
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Control of 
nosocomial 
antimicrobial 
resistance 
Figure 1. Coordinated multi-disciplinary approach to control of nosocomial antibiotic resistance. 
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hand hygiene requires a concerted effort (multi- 
disciplinary with continuous educational campaigns), 
and dedication of not insignificant resources.31 
Problems faced by ICTs are exacerbated by 
multiple intra-hospital patient transfers (moving an 
infected patient around the hospital is a sure way to 
disseminate nosocomial pathogens), inappropriate 
admissions (e.g. to cold surgical wards), staffing short- 
ages (nursing, medical and domestic), and difficulties 
in ensuring or maintaining basic infection control 
education among locum/temporary staff. As with 
attempts at implementing antimicrobial control policies, 
ICTs are often faced with the same lack of adminis- 
trative support. 
The successful delivery of an integrated approach to 
combat nosocomial antimicrobial resistance requires 
coordination of the various control and surveillance 
systems. There needs to be a clear clinical lead-either 
the expansion of an existing role or the creation of a new 
post. Acar and Goldstein in 1998 forecast that ‘a 
specialist in charge of bacterial resistance will be needed 
in hospitals to integrate . . . information in order to best 
use antibiotics and to ensure accountability for the 
quality of that use’.32 This predicted specialist role could 
be expanded to oversee the delivery of an integrated 
infection control, antimicrobial control and surveillance 
policy. 
CONCLUSIONS 
The control of antibiotic resistance within hospitals 
requires a coordinated multidisciplinary approach 
(Figure 1). Rationalization of antibiotic prescribing in 
the form of implementation of effective antibiotic 
policies is but one part of the strategy. There is a need 
for the development and implementation of surveillance 
systems for the generation and processing of relevant 
epidemiological data relating to antimicrobial resistance 
and hospital-acquired infections. There has to be in 
place an organizational framework for continuous 
monitoring of antibiotic prescribing and infection 
control procedure compliance and feedback. Raising the 
profile of infection control is a priority for all hospitals. 
Infection control, antibiotic control and surveillance 
must be integrated and co-ordinated by a team of 
healthcare professionals, which includes microbiologists, 
infectious disease physicians, the ICT, pharmacists, data 
management and IT resources, but with a clear line of 
accountability to a lead person. The appointment of an 
anti-infective pharmacist to the team should be given 
serious consideration. Finally, the successful implemen- 
tation of any strategy for the control of antimicrobial 
resistance within the hospital setting is dependent upon 
the support and commitment of the hospital leadership 
and administration. 
Success depends upon the hospital leadership- 
making the campaign against antimicrobial resistance a 
strategic priority and marshalling a multi-disciplinary 
prevention and controlprogramme under the aegis of the 
hospital’s overall efforts to improve quality.29 
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